Cas:51787-75-8 4,4′-Dinitro-2-biphenylamine manufacturer & supplier

We serve Chemical Name:4,4′-Dinitro-2-biphenylamine CAS:51787-75-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

4,4'-Dinitro-2-biphenylamine

Chemical Name:4,4′-Dinitro-2-biphenylamine
CAS.NO:51787-75-8
Synonyms:5-nitro-2-(4-nitrophenyl)phenylamine;1-amino-3,8-dinitrobiphenyl;4,4′-Dinitro-biphenyl-2-ylamin;4,4′-Dinitro-2-biphenylamine;2-amino-4,4′-dinitrobiphenyl;4,4′-dinitrobiphenyl-2-amine;4.4′-Dinitro-2-amino-biphenyl;amino-2 dinitro-4,4′ biphenyle;4,4′-Dinitrobiphenyl-2-ylamine;(1,1′-Biphenyl)-2-amine,4,4′-dinitro;MFCD00075056;4,4`-Dinitro-2-biphenylamine;4,4′-Dinitro-(1,1′-biphenyl)-2-amine;EINECS 257-417-8
Molecular Formula:C12H9N3O4
Molecular Weight:259.21800
HS Code:2921499090

Physical and Chemical Properties:
Melting point:208-210ºC(lit.)
Boiling point:472ºC at 760 mmHg
Density:1.434g/cm3
Index of Refraction:1.678
PSA:117.66000
Exact Mass:259.05900
LogP:4.37980

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:


Contact us for information like 5-nitro-2-(4-nitrophenyl)phenylamine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,EINECS 257-417-8 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,EINECS 257-417-8 Use and application,2-amino-4,4′-dinitrobiphenyl technical grade,usp/ep/jp grade.


Related News: There are also new directives that relate to US citizens. 4,4′-Dinitro-2-biphenylamine manufacturer Financial toxicity (FT) is more prevalent among individuals with atherosclerotic cardiovascular disease (ASCVD) than individuals with cancer, according to a study published in the June 1 issue of JACC: CardioOncology. 4,4′-Dinitro-2-biphenylamine supplier As the first-to-market BTK inhibitor, Imbruvica has been treating front-line CLL patients since its monotherapy go-ahead in early 2016. But it’s now facing competition from AstraZeneca’s Calquence, which just detailed a head-to-head safety advantage over Imbruvica in previously treated CLL. 4,4′-Dinitro-2-biphenylamine vendor There are also new directives that relate to US citizens. 4,4′-Dinitro-2-biphenylamine factory Financial toxicity (FT) is more prevalent among individuals with atherosclerotic cardiovascular disease (ASCVD) than individuals with cancer, according to a study published in the June 1 issue of JACC: CardioOncology.